DNDi is a non-profit organization dedicated mainly to the research and development of new treatments for patients suffering from neglected diseases including neglected tropical diseases.
Since its founding in 2003 with a portion of 1999 Nobel Peace Prize awarded to Médecins Sans Frontières (MSF), the organization has delivered 12 new treatments in the past 20 years.
In this webinar, we will introduce DNDi’s achievements and activities to date, and discuss expectations for Japan and the role of the Japan office in the future outlook.
This event will be hosted in English.
Tomoyoshi Nozaki, Board of Directors, DNDi Japan
|16:10||Session 1: DNDi past – present – future: Increasing presence of Japanese partners|
Fumiko Hirabayashi, Board Member, DNDi Japan
Kaori Nakatani, Japan Director, DNDi
Osamu Kunii, CEO, GHIT Fund
Shinjiro Murata, Director General, MSF Japan
|16:45||Session 2: Challenging climate sensitive diseases|
Neelika Malavige, Head of Dengue Global Programme and Scientific Affairs, DNDi
Ayano Kunimitsu, member of the House of Representatives, Secretary General of the NTD Parliamentary League
Luis Pizarro, Executive Director, DNDi